Immune System Diseases

The Hospital Marina Baixa De La Vila Joiosa conducts research on disorders where the immune system attacks the body, including Systemic Lupus Erythematosus and Rheumatoid Arthritis. Trials aim to evaluate new biologic agents and compare safety profiles of emerging therapies.

  • Belimumab efficacy in early lupus
  • Baricitinib versus TNF inhibitors for joint disease
  • Immune modulation strategies across autoimmune conditions

The goal is to improve disease control and reduce complications by testing innovative treatments that target immune pathways.

Skin and Connective Tissue Diseases

Studies at the site focus on chronic skin conditions such as Atopic Dermatitis, Plaque Psoriasis, and Nummular Eczema. Research evaluates both topical and systemic therapies to enhance skin clearance and quality of life.

  • Ruxolitinib cream for moderate atopic dermatitis
  • Adjusted brodalumab dosing for heavy patients with severe psoriasis
  • Lebrikizumab effectiveness in nummular eczema

These trials seek to determine the safety and efficacy of novel agents, offering alternatives for patients who have not responded to standard treatments.

Virus Diseases

The department runs several investigations targeting HIV and HIV‑1 infection, focusing on long‑term viral suppression and treatment simplification for diverse patient groups.

  • DTG/3TC maintenance therapy compared with standard regimens
  • Long‑acting cabotegravir plus rilpivirine in adults over 60
  • Switch strategies to injectable therapies for stable patients

The purpose is to assess new therapeutic options that maintain viral control while reducing pill burden and side effects.

Immune System Phenomena

Research also explores fundamental immune system phenomena that underlie multiple diseases, linking insights from dermatology and rheumatology to viral immunity.

  • Cytokine inhibition across psoriasis and ulcerative colitis
  • JAK pathway targeting in atopic dermatitis
  • Biomarker studies to predict treatment response

By deciphering immune mechanisms, the site aims to guide the development of precision medicines for a range of inflammatory and infectious conditions.